117550-35-3 Usage
Uses
Used in Pharmaceutical Industry:
(2-hydroxymethyl-phenyl)-urea is used as a building block for synthesizing various drugs and biologically active compounds. Its unique structure allows for the development of new pharmaceuticals with potential therapeutic benefits.
Used in Anticancer Applications:
(2-hydroxymethyl-phenyl)-urea is used as an anticancer and antiproliferative agent. It has been studied for its potential to inhibit the growth and proliferation of cancer cells, making it a promising candidate for cancer treatment.
Used in Enzyme Inhibition:
(2-hydroxymethyl-phenyl)-urea is used in inhibiting the enzyme dihydrofolate reductase. This enzyme plays a crucial role in the synthesis of DNA and RNA, and its inhibition can lead to the suppression of cancer cell growth.
Used in Agricultural Chemicals:
(2-hydroxymethyl-phenyl)-urea has been explored for its potential use in the production of herbicides and agricultural chemicals. Its chemical properties make it a candidate for developing new compounds to control the growth of unwanted plants and improve crop yields.
Check Digit Verification of cas no
The CAS Registry Mumber 117550-35-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,5,5 and 0 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 117550-35:
(8*1)+(7*1)+(6*7)+(5*5)+(4*5)+(3*0)+(2*3)+(1*5)=113
113 % 10 = 3
So 117550-35-3 is a valid CAS Registry Number.
117550-35-3Relevant academic research and scientific papers
Imidazopyridine compounds and processes for preparation thereof
-
, (2008/06/13)
The invention relates to an imidazopyridine compound of the formula: STR1 wherein R1 is lower alkynyl, lower alkynyloxy(lower)alkyl or N,N-di(lower)alkylamino(lower)alkynyl, R2 is lower alkyl, R3 is mono (or di or tri)-phenyl(lower)alkyl substituted by one or more substituent(s) selected from cyano, carbamoyl, mono (or di or tri(phenyl(lower)alkylamino, acylamino, carboxy, esterified carboxy, hydroxy, hydroxy(lower)alkyl, acyloxy(lower)alkyl, acyloxy, mono (or di or tri)phenyl(lower)alkoxy, lower alkoxy(lower)alkoxy, tetrahydropyranyloxy, and acylamino(lower)alkyl or mono (or di or tri) phenyl(lower)alkyl substituted by lower alkyl and one additional substituent selected from hydroxy(lower)alkyl, amino, N-lower alkyl-N-acylamino, mono (or di or tri)phenyl(lower)alkylamino, acylamino and lower alkylamino, and R4 is hydrogen or lower alkyl, and a pharmaceutically acceptable salt thereof, useful in the treatment of ulcers.